4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now
A new Jefferies research report focuses on some biotech and specialty pharmaceutical stocks that have had some headline and clinical issues muddy the waters.
A new Jefferies research report focuses on some biotech and specialty pharmaceutical stocks that have had some headline and clinical issues muddy the waters.
With the holiday shopping season in full-swing, you can bet the video game companies with the hot titles stand to have a huge fourth quarter.
A new research report from Deutsche Bank takes an in-depth look at how various banks will be affected by a rate hike and highlights three that could trade strong initially and sustain forward gains.
A new Deutsche Bank research report zeroes on four retailers the analysts think came away as the big winners this year.
A new research report from SunTrust Robinson Humphrey tracks the performance, or in most cases outperformance, of the debt of some top exploration and production companies.
On the close Tuesday, the PowerShares Dynamic exchange traded funds (ETFs) are set for a rebalance. These four stocks that are expected to have huge buying on the close Tuesday.
A new Merrill Lynch research report highlights the companies that will be a major part of what the analyst calls the climate change solution for a transforming world.
Buying high-yielding blue chips for 2016 makes good sense. The Federal Reserve interest rate increases over the next two years are expected to remain very small and very measured.
Deutsche Bank notes that despite a production decline, prices for oil stocks have had trouble gaining ground. These four leaders are the best way to play the energy sector now.
One of the best things a Wall Street firm can do is add an analyst to their research staff that has direct knowledge of the industry they cover from having worked in it. That’s…
They call it Black Friday for a reason, because generally retailers are “in the black” for the year by the time it rolls around and all the shopping for the day has been completed.…
Despite the howling from political candidates trying to make the top drug-makers their whipping boy in populist campaign efforts, the need and demand for pharmaceuticals will only continue. This is especially the case when you…
While the market has a shortened three and a half day trading week, many savvy and seasoned investors use the Thanksgiving break as a time to review their portfolios. It turns out that many of those…
While the determination on interest rates going higher isn’t a totally done deal, the signs pointing to a December lift-off are about as strong as they can be. Toss in the fact that Federal…
The inevitable finally seems to be right around the corner. Barring some huge geopolitical storm in the next three weeks, the Federal Reserve is expected to raise interest rates for the first time in…
With Thanksgiving on Thursday and a shortened trading day on Friday, the markets will start the traditional slow down tomorrow as folks on Wall Street take some time off to spend with family and…
As 2015 heads towards the final month of trading, it has been a seesaw year for investors. The Federal Reserve also seems as though they are looking to start raising interest rates in December.…
While the natural inclination is to think that corporate executives would like to sell stock into a big market rally like the one this past week, the data sure didn’t confirm that.
On a week when the market had some of its best upside trading in months, conventional wisdom would seem to dictate that insider buying would be slow.
In a new report, UBS gives a wrap-up to its recent global technology conference and included some interesting thoughts on the beaten-down cybersecurity stocks.